Results 31 to 40 of about 13,925,210 (307)
Second-Line Treatment of Ovarian Cancer [PDF]
Abstract Patients with epithelial ovarian cancer are often diagnosed with advanced-stage disease. Although clinical complete remissions are obtained in the majority of patients through a combination of cytoreductive surgery and chemotherapy, relapse is common.
M, Markman, M A, Bookman
openaire +2 more sources
Second-line Antiretriviral Therapy in Northern Tanzania [PDF]
Following rapid expansion of anti-retroviral therapy (ART) in resource limited settings, some patients are failing and require switching to second line ART.
Omari, Habib
core +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Second-line therapies in immune thrombocytopenia [PDF]
Abstract Immune thrombocytopenia (ITP) is a rare, acquired autoimmune condition characterized by a low platelet count and an increased risk of bleeding. Although many children and adults with ITP will not need therapy beyond historic first-line treatments of observation, steroids, intravenous immunoglobulin (IVIG), and anti-D globulin,
Rachael F, Grace, Cindy, Neunert
openaire +2 more sources
Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes. [PDF]
BACKGROUND After first-line antiretroviral therapy (ART) failure, the importance of change in nucleoside reverse transcriptase inhibitor (NRTI) in second-line is uncertain due to the high potency of protease inhibitors used in second-line. SETTING
Horsburgh, C Robert +41 more
core +2 more sources
Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari +5 more
wiley +1 more source
Direct mass spectrometry (MS) analysis of human tissue at the molecular level could gain insight into biomarker discovery and disease diagnosis. Detecting metabolite profiles of tissue sample play an important role in understanding the pathological ...
Dasheng Liu +10 more
doaj +1 more source
Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa [PDF]
To measure rates and predictors of virologic failure and switch to second-line antiretroviral therapy (ART) in South ...
Olivia Keiser +36 more
core +3 more sources
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman +9 more
wiley +1 more source
Background: Treatment of metastatic and locally advanced unresectable esophagogastric adenocarcinoma (EGA) after first-line therapy has limited efficacy. Sacituzumab govitecan (SG) is an antibody-drug conjugate (ADC) linking a TROP-2-directed antibody to
B. Kobitzsch +7 more
doaj +1 more source

